Trial Profile
Phase I trial of NKP 1339 in patients with advanced solid tumours.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs BOLD 100 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Jun 2011 New trial record